Published in Pharmacol Biochem Behav on March 05, 2013
Modulation of nicotine effects on selective attention by DRD2 and CHRNA4 gene polymorphisms. Psychopharmacology (Berl) (2015) 0.80
Nicotine reduces distraction under low perceptual load. Psychopharmacology (Berl) (2014) 0.78
Nicotinergic Modulation of Attention-Related Neural Activity Differentiates Polymorphisms of DRD2 and CHRNA4 Receptor Genes. PLoS One (2015) 0.78
Moderation of nicotine effects on covert orienting of attention tasks by poor placebo performance and cue validity. Pharmacol Biochem Behav (2016) 0.75
The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia (1971) 86.03
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev (1993) 19.60
Orienting of attention. Q J Exp Psychol (1980) 19.05
Smoking, stress, and negative affect: correlation, causation, and context across stages of smoking. Psychol Bull (2003) 6.62
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) (2005) 3.92
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl) (1992) 2.97
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat (2004) 2.89
Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs (2000) 2.82
Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl) (2005) 2.49
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics (1997) 2.28
Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol (2004) 2.22
Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst (1998) 2.16
Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) (1998) 2.01
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patch. Pharmacogenetics (2004) 1.49
Asymmetric neural control systems in human self-regulation. Psychol Rev (1984) 1.46
D2 dopamine receptor gene and cigarette smoking: a reward gene? Med Hypotheses (1994) 1.42
Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology (2005) 1.39
Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol (2003) 1.33
Personality, psychopathology, and nicotine response as mediators of the genetics of smoking. Behav Genet (1995) 1.30
A double-blind placebo controlled experimental study of nicotine: I--effects on incentive motivation. Psychopharmacology (Berl) (2006) 1.28
Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. Nicotine Tob Res (2004) 1.27
Effects of altering brain cholinergic activity on covert orienting of attention: comparison of monkey and human performance. Psychopharmacology (Berl) (1997) 1.27
The subjective effects of nicotine: methodological issues, a review of experimental studies, and recommendations for future research. Nicotine Tob Res (2002) 1.24
Cognitive and psychological correlates of smoking abstinence, and predictors of successful cessation. Addict Behav (2004) 1.17
Personality and the inheritance of smoking behavior: a genetic perspective. Behav Genet (1995) 1.12
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J (2007) 1.08
Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. Nicotine Tob Res (2007) 1.00
fMRI data predict individual differences of behavioral effects of nicotine: a partial least square analysis. J Cogn Neurosci (2007) 0.97
Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing. Nicotine Tob Res (2005) 0.97
Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats. Pharmacol Biochem Behav (2006) 0.95
Association of serotonin transporter genotype with selective processing of smoking-related stimuli in current smokers and ex-smokers. Nicotine Tob Res (2005) 0.95
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. J Abnorm Psychol (2009) 0.94
Effects of nicotine on affect are moderated by stressor proximity and frequency, positive alternatives, and smoker status. Nicotine Tob Res (2008) 0.94
Subjective correlates of cigarette-smoking-induced elevations of peripheral beta-endorphin and cortisol. Psychopharmacology (Berl) (1992) 0.93
Effects of nicotine on attention and inhibitory control in healthy nonsmokers. Exp Clin Psychopharmacol (2011) 0.93
Nicotine decreases attentional bias to negative-affect-related Stroop words among smokers. Nicotine Tob Res (2008) 0.92
Effects of nicotine on brain responses to emotional pictures. Nicotine Tob Res (2004) 0.86
Emotional stimuli and context moderate effects of nicotine on specific but not global affects. Exp Clin Psychopharmacol (2008) 0.83
Creating single-subject design graphs in Microsoft Excel 2007. J Appl Behav Anal (2009) 2.26
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav (2006) 1.63
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin (2005) 1.26
Extended Analysis of Empirical Citations with Skinner's Verbal Behavior: 1984-2004. Behav Anal (2007) 1.25
Mood disturbance fails to resolve across 31 days of cigarette abstinence in women. J Consult Clin Psychol (2002) 1.19
Using a computer simulation of three slot machines to investigate a gambler's preference among varying densities of near-miss alternatives. Behav Res Methods (2007) 1.00
Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. Nicotine Tob Res (2007) 1.00
Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. Nicotine Tob Res (2004) 0.99
Dopamine receptor (DRD2) genotype-dependent effects of nicotine on attention and distraction during rapid visual information processing. Nicotine Tob Res (2005) 0.97
Identification of a nuclear export signal and protein interaction domains in deformed epidermal autoregulatory factor-1 (DEAF-1). J Biol Chem (2004) 0.95
Effects of nicotine on affect are moderated by stressor proximity and frequency, positive alternatives, and smoker status. Nicotine Tob Res (2008) 0.94
Neurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch. J Abnorm Psychol (2009) 0.94
Gene-environment interactions across development: Exploring DRD2 genotype and prenatal smoking effects on self-regulation. Dev Psychol (2009) 0.92
Nicotine decreases attentional bias to negative-affect-related Stroop words among smokers. Nicotine Tob Res (2008) 0.92
Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl) (2009) 0.89
Effects of transdermal nicotine on lateralized identification and memory interference. Hum Psychopharmacol (2003) 0.89
Effects of nicotine on brain responses to emotional pictures. Nicotine Tob Res (2004) 0.86
Multivariate framework of the Brief Questionnaire of Smoking Urges. Drug Alcohol Depend (2007) 0.86
Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence. Nicotine Tob Res (2003) 0.85
DRD2-related TaqIA polymorphism modulates motivation to smoke. Nicotine Tob Res (2009) 0.84
Marijuana and tobacco exposure predict affect-regulation expectancies in dual users. Addict Behav (2008) 0.84
Effects of nicotine and depressive traits on affective priming of lateralized emotional word identification. Exp Clin Psychopharmacol (2008) 0.83
Emotional stimuli and context moderate effects of nicotine on specific but not global affects. Exp Clin Psychopharmacol (2008) 0.83
Deformed epidermal autoregulatory factor-1 (DEAF1) interacts with the Ku70 subunit of the DNA-dependent protein kinase complex. PLoS One (2012) 0.83
Nicotine primes attention to competing affective stimuli in the context of salient alternatives. Exp Clin Psychopharmacol (2010) 0.80
Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory. Exp Clin Psychopharmacol (2009) 0.78
Brain activity during anticipation of smoking-related and emotionally positive pictures in smokers and nonsmokers: a new measure of cue reactivity. Nicotine Tob Res (2008) 0.78
Nicotine differentially modulates antisaccade eye-gaze away from emotional stimuli in nonsmokers stratified by pre-task baseline performance. Psychopharmacology (Berl) (2012) 0.76
Commentary on Etter et al. (2013): The ups and downs of nicotine withdrawal and methods to study the process. Addiction (2013) 0.75
Effects of Intermittent Versus Continuous Walking on Distance Walked and Fatigue in Persons With Multiple Sclerosis: A Randomized Crossover Trial. J Neurol Phys Ther (2015) 0.75
A Survey of ASAM Members' Knowledge, Attitudes, and Practices in Urine Drug Testing. J Addict Med (2015) 0.75